A pharmaceutical preparation of ET18-OCH3? for intravenous administration containing a lipophilic oil-in-water emulsion can be used to administer high doses of the pharmacon ET18-OCH3? without side effects. The lipophilic emulsions in the preparation contain ordinary lipophilic particles of the size of chylomicrons. The active substance and the lipophilic emulsion in the pharmaceutical preparation are usually administered intravenously at the same time. However, the oil-in-water emulsion and the active substance can also be administered separately or at intervals. For this reason, a pharmaceutical preparation is described in which the active substance ET18-OCH3? and the lipophilic emulsion exist as a combination preparation. Also described is the use of ET18-OCH3? and the lipophilic emulsion to manufacture drugs which have an antiproliferative effect and are used to suppress immunological reactions and to treat tumours, as well as to treat multiple sclerosis and autoimmune diseases.
展开▼
